1. 28 CHARACTERISTICS AND OUTCOMES OF PROSPECTIVELY REPORTED PREGNANCIES EXPOSED TO CERTOLIZUMAB PEGOL FROM A SAFETY DATABASE. (18th January 2018) Authors: Afzali, Anita; Clowse, Megan E B; Scheuerle, Angela E; Chambers, Christina; Kimball, Alexa B; Cush, John J; Cooney, Maureen; Shaughnessy, Laura; Vanderkelen, Mark; Förger, Frauke Journal: Inflammatory bowel diseases Issue: Volume 24(2018)Supplement 1 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial. (21st January 2023) Authors: Thaçi, Diamant; Vender, Ron; de Rie, Menno A; Conrad, Curdin; Pariser, David M; Strober, Bruce; Vanvoorden, Veerle; Wang, Maggie; Madden, Cynthia; de Cuyper, Dirk; Kimball, Alexa B Journal: British journal of dermatology Issue: Volume 188:Number 1(2023) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials. Issue 10378 (4th March 2023) Authors: Kimball, Alexa B; Jemec, Gregor B E; Alavi, Afsaneh; Reguiai, Ziad; Gottlieb, Alice B; Bechara, Falk G; Paul, Carle; Giamarellos Bourboulis, Evangelos J; Villani, Axel P; Schwinn, Andreas; Ruëff, Franziska; Pillay Ramaya, Larisha; Reich, Adam; Lobo, Ines; Sinclair, Rodney; Passeron, Thierry; Mart... Journal: Lancet Issue: Volume 401:Issue 10378(2023) Page Start: 747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials. Issue 10091 (15th July 2017) Authors: Reich, Kristian; Papp, Kim A; Blauvelt, Andrew; Tyring, Stephen K; Sinclair, Rodney; Thaçi, Diamant; Nograles, Kristine; Mehta, Anish; Cichanowitz, Nicole; Li, Qing; Liu, Kenneth; La Rosa, Carmen; Green, Stuart; Kimball, Alexa B Journal: Lancet Issue: Volume 390:Issue 10091(2017) Page Start: 276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗